Biological heterogeneity in localized high-risk prostate cancer (LHRPC) from a study of neoadjuvant abiraterone acetate plus leuprolide acetate (LHRHa) versus LHRHa.

被引：16

作者：

Efstathiou, Eleni

Li, Weimin

Gormley, Michael

McMullin, Ryan

Ricci, Deborah Sokol

Davis, John W.

Tapia, Elsa M. Li Ning

Troncoso, Patricia

Titus, Mark Anton

Hoang, Anh

Wen, Sijin

Zurita, Amado J.

Tran, Namphuong

Peng, Weimin

Kheoh, Thian

Molina, Arturo

Logothetis, Christopher

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Janssen Res & Dev, Spring House, PA USA

[3] LabConnect LLC, Seattle, WA USA

[4] Janssen Res & Dev, Raritan, NJ USA

[5] W Virginia Univ, Sch Publ Hlth, Morgantown, WV 26506 USA

[6] Janssen Res & Dev, Los Angeles, CA USA

[7] Janssen Res & Dev, San Diego, CA USA

[8] Janssen Res & Dev, Menlo Pk, CA USA

来源：

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.5005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

5005

引用

页数：1